secwatch.observer — SEC 8-K summary
======================================

Issuer:     CAPRICOR THERAPEUTICS, INC. (CAPR)
CIK:        0001133869
Form:       8-K
Filed at:   2023-07-13T23:59:59+00:00
Accession:  0001558370-23-011854
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Capricor board member Manzo resigns; appoints Paul Auwaerter, M.D. to board
---------------------------------------------------------------------------

- Louis Manzo resigned from board effective July 11, 2023, with no disagreement over operations.
- Manzo entered a consulting agreement to perform investor relations services for Capricor.
- Paul Auwaerter, M.D. appointed to board; receives initial option grant of 115,000 shares vesting over 3 years.
- Auwaerter is Clinical Director at Johns Hopkins Division of Infectious Diseases with over 30 years experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133869/000155837023011854/0001558370-23-011854-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133869/000155837023011854/capr-20230711x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-011854

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer